Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target increased by analysts at Piper Sandler from $67.00 ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...

Lemonade (NYSE:LMND – Free Report) had its price objective reduced by Piper Sandler from $44.00 to $34.00 in a report ...

Piper Sandler lowered the firm’s price target on Dyne Therapeutics (DYN) to $48 from $53 following ATM dilution, while keeping an Overweight ...

Andy Laperriere, Piper Sandler head of U.S. policy, joins 'The Exchange' to discuss the questions around the budget ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...

LONDON & NEW YORK, February 19, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ahsan Khan as a managing director along with Jonathan ...

Piper Sandler reported Q4 2024 adjusted net revenues of $499 million, exceeding analysts' revenue estimates of $454.36 million. Adjusted EPS of $4.80 also surpassed the analysts' EPS estimate of ...

Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional ...

MINNEAPOLIS, February 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of ...